The vascular stents market plays a vital role in the field of interventional cardiology and vascular surgery, providing essential solutions for treating vascular diseases, including coronary artery disease (CAD), peripheral artery disease (PAD), and renal artery disease. As the prevalence of cardiovascular conditions continues to rise globally, the demand for vascular stents is also expected to grow significantly. The global vascular stents market was valued at nearly USD 10.57 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.50% from 2025 to 2034, reaching a value of approximately USD 18.06 billion by 2034.

This article will explore the current trends and future prospects of the vascular stents market, with insights into its size, share, growth drivers, opportunities, challenges, and competitive landscape.

Overview of the Vascular Stents Market

Vascular stents market are small, flexible tubes that are used to treat narrowed or blocked blood vessels. They are commonly deployed through a minimally invasive procedure known as angioplasty, where a balloon is used to widen the narrowed vessel, and the stent is placed to keep the vessel open. Stents are primarily used in treating cardiovascular diseases, particularly coronary artery disease, which occurs when the arteries that supply blood to the heart become blocked or narrowed.

The vascular stents market has seen rapid growth due to increasing incidences of heart diseases, a rising aging population, and advancements in stent technology. Stents can be categorized into different types, including bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable stents. Drug-eluting stents, which release medication to prevent the artery from closing again, are becoming increasingly popular due to their superior performance compared to bare-metal stents.

Advancements in materials, such as the development of biocompatible and bioresorbable stents, are also enhancing the market, providing additional benefits such as reduced risk of restenosis and lower long-term complications.

Get a free sample request: https://www.expertmarketresearch.com/reports/vascular-stents-market/requestsample

Size and Share of the Vascular Stents Market

The global vascular stents market was valued at approximately USD 10.57 billion in 2024 and is expected to grow at a CAGR of 5.50% between 2025 and 2034, reaching an estimated value of USD 18.06 billion by 2034. This steady growth is driven by multiple factors, including the rising incidence of vascular diseases, the aging global population, and technological advancements in stent materials and delivery systems.

Market Segmentation

The vascular stents market can be segmented based on product type, application, end-user, and geography.

  • By Product Type
    • Bare-Metal Stents (BMS): Bare-metal stents are the original type of stent used in vascular procedures. They are made from metal and provide mechanical support to the blood vessel. However, they have a higher rate of restenosis, or re-narrowing of the artery, compared to newer stent technologies.
    • Drug-Eluting Stents (DES): Drug-eluting stents are coated with medication that slowly releases to prevent the artery from narrowing again after the procedure. DES are preferred over BMS due to their ability to reduce restenosis rates significantly.
    • Bioresorbable Stents: These are newer stents made from materials that dissolve over time. Bioresorbable stents are expected to gain popularity due to their ability to provide temporary support to the blood vessel while eventually being absorbed by the body, reducing long-term complications.
  • By Application
    • Coronary Artery Disease (CAD): CAD is one of the most common cardiovascular conditions treated using vascular stents. Stents are used to restore blood flow to the heart by widening narrowed coronary arteries.
    • Peripheral Artery Disease (PAD): PAD occurs when the blood vessels outside the heart and brain become narrowed or blocked, affecting limbs. Stents are used to treat PAD, particularly in the femoral and iliac arteries.
    • Renal Artery Disease: Renal artery disease occurs when the blood supply to the kidneys is compromised, leading to kidney dysfunction. Vascular stents are used to restore blood flow in such cases.
    • Carotid Artery Disease: Stents are also used in the treatment of carotid artery disease, which can lead to strokes if left untreated.
  • By End-User
    • Hospitals and Clinics: Hospitals and specialized clinics are the primary end-users of vascular stents, providing interventional cardiology procedures and surgeries to patients.
    • Ambulatory Surgical Centers (ASCs): ASCs are also increasingly being used for vascular stent procedures, particularly for minimally invasive interventions.
  • By Geography
    • North America: North America holds a significant share of the global vascular stents market, driven by high healthcare expenditure, advanced medical infrastructure, and the rising prevalence of heart diseases.
    • Europe: Europe is another major market, with significant adoption of advanced vascular stent technologies and growing awareness about cardiovascular health.
    • Asia-Pacific: The Asia-Pacific region is expected to witness the highest growth rate due to increasing healthcare investments, rising incidences of cardiovascular diseases, and the expanding healthcare infrastructure.
    • Rest of the World: Latin America, the Middle East, and Africa are witnessing moderate growth due to improving healthcare systems and increasing patient awareness about cardiovascular diseases.

Market Dynamics and Trends

Key Drivers of Market Growth

  • Rising Incidence of Cardiovascular Diseases The increasing prevalence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, is a major driver of the vascular stents market. Factors such as unhealthy lifestyles, poor diet, smoking, and an aging population are contributing to the rise in these conditions, leading to a higher demand for stent procedures.
  • Technological Advancements in Stent Design The continuous innovation in vascular stent technology, including the development of drug-eluting stents (DES) and bioresorbable stents, is enhancing treatment outcomes and reducing the risk of complications such as restenosis and thrombosis. These advancements are significantly boosting market growth.
  • Aging Population The global aging population is another key factor contributing to the growth of the vascular stents market. As people age, they are more likely to experience cardiovascular diseases, increasing the need for stent procedures.
  • Minimally Invasive Procedures The increasing preference for minimally invasive procedures in cardiovascular treatments is also driving the adoption of vascular stents. Stent procedures are typically performed through angioplasty, a less invasive alternative to traditional surgeries, which is beneficial for both patients and healthcare providers.

Emerging Trends in the Vascular Stents Market

  • Bioresorbable Stents Bioresorbable stents are an emerging trend in the vascular stents market. These stents are made from biodegradable materials and provide temporary support to the blood vessel, eventually dissolving without leaving a permanent implant in the body. They have the potential to reduce long-term complications and improve patient outcomes.
  • Improved Drug-Eluting Stents Drug-eluting stents continue to evolve, with the development of new drugs and coatings that reduce restenosis and thrombosis rates. New-generation drug-eluting stents are expected to drive market growth by offering better safety profiles and long-term results.
  • Technological Integration The integration of advanced technologies such as 3D printing, robotics, and artificial intelligence (AI) in vascular stent procedures is improving the precision of stent placements and reducing procedural complications. These technologies are expected to become more prevalent in the coming years.

Growth and Future Prospects

The vascular stents market is set for continued growth, driven by factors such as rising healthcare investments, increasing cardiovascular disease prevalence, and technological advancements. The market is projected to reach USD 18.06 billion by 2034, growing at a CAGR of 5.50%.

Growth Opportunities

  • Expansion in Emerging Markets The growing healthcare infrastructure in emerging markets such as India, China, and Brazil presents significant opportunities for market expansion. These regions are witnessing an increase in cardiovascular diseases, and the demand for advanced stent procedures is expected to rise.
  • Technological Advancements and Product Innovation The development of next-generation drug-eluting stents, bioresorbable stents, and minimally invasive stent placement technologies presents numerous growth opportunities. Companies that invest in R&D to improve the efficacy and safety of stents will have a competitive advantage in the market.
  • Strategic Collaborations and Acquisitions Partnerships and acquisitions among key players can lead to the development of innovative stent technologies, increasing market share and access to new patient demographics. Companies are also exploring mergers with hospitals and clinics to increase their service offerings and improve patient access to stent procedures.

Market Opportunities and Challenges

Opportunities

  • Rising Adoption of Minimally Invasive Procedures: As patients increasingly prefer minimally invasive treatments, the demand for vascular stent procedures will continue to rise, presenting significant growth opportunities for market players.
  • Focus on Expanding Healthcare Access: In developing regions, increasing access to healthcare services, along with rising awareness about cardiovascular diseases, will fuel the demand for vascular stents.

Challenges

  • Cost of Stent Procedures: The high cost of vascular stent procedures, including the stent itself, surgical costs, and post-procedure care, may limit market growth, particularly in low-income regions.
  • Risk of Complications: While vascular stents are generally safe, complications such as restenosis, thrombosis, and stent fractures remain challenges that can hinder the adoption of certain stent technologies.

Competitor Analysis

The vascular stents market is highly competitive, with several leading players driving innovation and market growth. Key players in the market include:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik, Inc.
  • MicroPort Scientific Corporation
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Meril Life Sciences Pvt. Ltd.
  • Medtronic
  • BD
  • Biosensors International Group, Ltd.
  • Lepu Medical Technology
  • Koninklijke Philips N.V.
  • Teleflex Incorporated

These companies are focusing on research and development, expanding their product portfolios, and entering into strategic collaborations to enhance their market presence and compete effectively in the vascular stents market.

The vascular stents market is expected to experience substantial growth over the next decade, driven by the increasing prevalence of cardiovascular diseases, technological innovations, and a rising preference for minimally invasive procedures. While challenges such as high costs and potential complications remain, the ongoing development